| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,700 |
1,581 |
$141K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
901 |
848 |
$45K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
587 |
551 |
$17K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
135 |
133 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
249 |
242 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
791 |
774 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
383 |
358 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
86 |
79 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
169 |
164 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
17 |
17 |
$2K |
| 99051 |
|
161 |
144 |
$2K |
| 87428 |
|
18 |
18 |
$1K |
| 94760 |
|
35 |
35 |
$106.75 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$28.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
25 |
$28.20 |
| 99080 |
|
25 |
24 |
$0.00 |
| 99000 |
|
61 |
59 |
$0.00 |